SCHEMBL7745852

SCHEMBL7745852

O=c1c2ccccc2n(Cc2nc3ccccc3n2CCCCF)c(=O)n1C1CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.59
TSHR P16473 4/20 0.50
NPSR1 Q6W5P4 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
CRHBP P24387 1/20 0.50
CRHR2 Q13324 1/20 0.50
ALDH1A1 P00352 3/20 0.48
POLB P06746 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
KMT2A Q03164 1/20 0.40
RECQL P46063 1/20 0.38
TOP2A P11388 1/20 0.37
PTK2B Q14289 1/20 0.36
HPGD P15428 1/20 0.36
CACNA1G O43497 1/20 0.36
CACNA1H O95180 1/20 0.36
CXCR4 P61073 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746055 0.91 CYP3A4 (0.72) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL6783757 0.90 CYP3A4 (0.54) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL6247449 0.89 CYP3A4 (0.49) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL8366214 0.87 CYP3A4 (0.54) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL7741783 0.87 CYP3A4 (0.54) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL6479793 0.82 CYP3A4 (0.50) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL6274097 0.82 CYP3A4 (0.58) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL7891212 0.81 NPSR1 (0.46) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL6243686 0.80 CYP3A4 (0.43) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP
SCHEMBL6264028 0.76 NPSR1 (0.45) CYP3A4TSHRNPSR1SMN1; SMN2CRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed